Other combined immunodeficiencies digital illustration

Other Combined Immunodeficiencies: What You Need to Know

Immunodeficiencies are a group of disorders that weaken the body's immune system, making it more vulnerable to infections. Combined immunodeficiencies (CIDs) are a specific type of immunodeficiency disorder that affect multiple components of the immune system. While there are many types of CIDs, this article will focus on the lesser-known "other" combined immunodeficiencies.

  1. Omenn Syndrome: This rare CID is caused by genetic mutations that affect the development of immune cells called T-cells. Symptoms include rash, enlarged lymph nodes, and recurrent infections.
  2. Bare Lymphocyte Syndrome: This CID affects the major histocompatibility complex (MHC) molecules, which are responsible for identifying foreign substances in the body. Symptoms include recurrent infections and increased susceptibility to cancer.
  3. MHC Class II Deficiency: Similar to Bare Lymphocyte Syndrome, this CID affects the MHC molecules responsible for identifying foreign substances. Symptoms include recurrent infections and autoimmune disorders.
  4. Combined Immunodeficiency with Multiple Intestinal Atresia (CI-MIA): This CID affects the development of the immune system and the digestive system. Symptoms include recurrent infections and intestinal blockages.

Diagnosis of other CIDs can be difficult, as symptoms can vary and overlap with other conditions. However, early diagnosis is important to prevent severe infections and complications.

Treatment for other CIDs typically involves a combination of immunoglobulin replacement therapy, antibiotics, and antiviral medications. In severe cases, a bone marrow or stem cell transplant may be necessary.

If you or a loved one are experiencing recurrent infections or other symptoms of immunodeficiency, it's important to talk to a healthcare provider. With proper diagnosis and treatment, those with other CIDs can live healthy and fulfilling lives.

Diagnosis Codes for Other combined immunodeficiencies | D81.89